methyl2,7-diazaspiro[3.5]nonane-7-carboxylatehydrochloride

Catalog No. :
ACLDZA056
CAS No. :
1628833-38-4
Molecular Formula :
C9H17ClN2O2
Molecular Weight :
220.70

IUPAC Name:methyl 2,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride

methyl2,7-diazaspiro[3.5]nonane-7-carboxylatehydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$351.00Login to see priceIn stockInquiry
250mg97%$561.00Login to see priceIn stockInquiry
500mg97%$934.00Login to see priceIn stockInquiry
1g97%$1400.00Login to see priceIn stockInquiry
5g97%$4199.00Login to see priceInquiryInquiry
10g97%$6999.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namemethyl2,7-diazaspiro[3.5]nonane-7-carboxylatehydrochloride
IUPAC Namemethyl 2,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride
MDL No.0
Molecular FormulaC9H17ClN2O2
Molecular Weight220.70
SMILESCOC(=O)N1CCC2(CC1)CNC2.Cl
InChI KeyOQLZWIZWNPGCFG-UHFFFAOYSA-N
Synonymmethyl 2,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride;methyl 2,7-diazaspiro[3.5]nonane-7-carboxylate;hydrochloride - [M20673]
CAS No.1628833-38-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLDZA056 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLDZA056 route product structure diagram
    ACLDZA0561628833-38-4 In Stock
Inquiry

2. ACLDZA056 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLDZA056 route product structure diagram
    ACLDZA0561628833-38-4 In Stock
Inquiry

Comments (0)